You are here

investment

02.07.2020

The Study on investment in the life sciences and healthcare industry in Catalonia 2020 showcases the robust health of the ecosystem, which has raised almost as much capital in the first half of 2020 as it did in all the rounds in 2019

02.07.2020

Barcelona, 2 July 2020 Life sciences and healthcare start-ups and companies in Catalonia managed to attract €112M of investment in 2019, a figure that has remained stable for four years in a row and is 3% higher than in 2018, according to the study presented today by Biocat, CataloniaBio & HealthTech and EY.

Both investors and experts believe this investment to be a...

23.06.2020

Covid-19 continues to be a trending topic, but research in other fields is regaining prominence

23.06.2020

Biocat has participated in drafting the report for the first time, contributing data and knowledge to provide context for the overall evolution of investment in recent years

22.06.2020

The visit looked at ways the government could maximize the economic impact of healthcare innovation in Catalonia

22.06.2020

It is the largest series A closed by a start-up of the sector in Spain

17.12.2019

Corporate operations and science publications round out December’s headlines in the ecosystem

15 new therapies made in Catalonia

15 new therapies ‘made in Catalonia’

The biomedical start-ups in the BioRegion of Catalonia currently have almost 20 therapies in the clinical phase. Some of these therapies may reach patients by 2025. What might the next made-in-Catalonia drugs be?

28.10.2019

New hires and investment in companies, hospitals and research centers round out the headlines for October

 

31.07.2019

In three minutes, we’ll summarize everything that has happened in the BioRegion in the month of July